A new type of toxin a-negative, toxin B-positive clostridium difficile strain lacking a complete tcdA gene

Journal of Clinical Microbiology

Volumn 53, Issue 2, 2015, Pages 692-695

  Janezic, Sandra ^a   Marín, Mercedes ^b,c   Martín, Adoración ^b,c   Rupnika, Maja ^d,e  

^a Environment and Food   (Slovenia)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^d UNIVERSITY OF MARIBOR   (Slovenia)

^e Centre of Excellence for Integrated Approaches in Chemistry and Biology of Proteins   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

CLOSTRIDIUM DIFFICILE TRANSFERASE NEGATIVE TOXINOTYPE; CLOSTRIDIUM TOXIN; GLUTAMATE DEHYDROGENASE; METRONIDAZOLE; UNCLASSIFIED DRUG; ACTIN-SPECIFIC ADP-RIBOSYLTRANSFERASE, CLOSTRIDIUM; BACTERIAL PROTEIN; BACTERIAL TOXIN; ENTEROTOXIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; TCDA PROTEIN, CLOSTRIDIUM DIFFICILE; TOXB PROTEIN, CLOSTRIDIUM DIFFICILE;

AGED; ARTICLE; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM ISOLATION; CASE REPORT; CELL CULTURE; CLOSTRIDIUM DIFFICILE INFECTION; COLONOSCOPY; CYTOTOXICITY ASSAY; DIARRHEA; DIVERTICULOSIS; ECHOGRAPHY; FECES ANALYSIS; GENE LOCUS; HUMAN; MALE; MEDICAL HISTORY; NONHUMAN; PATHOGENICITY ISLAND; SEQUENCE ANALYSIS; WEIGHT REDUCTION; CLASSIFICATION; CLUSTER ANALYSIS; DEFICIENCY; GENE ORDER; GENETICS; GENOMIC ISLAND; GENOTYPE; ISOLATION AND PURIFICATION; PEPTOCLOSTRIDIUM DIFFICILE; RIBOTYPING;

CLOSTRIDIUM DIFFICILE;

ADP RIBOSE TRANSFERASES; AGED; BACTERIAL PROTEINS; BACTERIAL TOXINS; CLOSTRIDIUM DIFFICILE; CLUSTER ANALYSIS; ENTEROTOXINS; GENE ORDER; GENOMIC ISLANDS; GENOTYPE; HUMANS; MALE; RIBOTYPING;

EID: 84921806187     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02211-14     Document Type: Article

References (16)

1. Centers for Disease Control and Prevention. 2012. Vital signs: preventing Clostridium difficile infections. MMWR Morb Mortal Wkly Rep 61: 157-162.
2. Eyre DW, Cule ML, Wilson DJ, Griffiths D, Vaughan A, O'Connor L, Ip CL, Golubchik T, Batty EM, Finney JM, Wyllie DH, Didelot X, Piazza P, Bowden R, Dingle KE, Harding RM, Crook DW, Wilcox MH, Peto TEA, Walker AS. 2013. Diverse sources of C. difficile infection identified on whole-genome sequencing. N Engl J Med 369:1195-1205. http://dx.doi.org/10.1056/NEJMoa1216064.
3. Magill SS, Edwards JR, Bamberg W, Beldavs ZG, Dumyati G, Kainer MA, Lynfield R, Maloney M, McAllister-Hollod L, Nadle J, Ray SM, Thompson DL, Wilson LE, Fridkin SK, Emerging Infections Program Healthcare-Associated Infections and Antimicrobial Use Prevalence Survey Team. 2014. Multistate point-prevalence survey of health care-associated infections. N Engl J Med 370:1198-1208. http://dx.doi.org/10.1056/NEJMoa1306801.
4. Gerding DN, Johnson S, Rupnik M, Aktories K. 2014. Clostridium difficile binary toxin CDT: mechanism, epidemiology, and potential clinical importance. Gut Microbes 5:15-27. http://dx.doi.org/10.4161/gmic.26854.
5. Carroll KC. 2011. Tests for the diagnosis of Clostridium difficile infection: the next generation. Anaerobe 17:170-174. http://dx.doi.org/10.1016/j.anaerobe.2011.01.002.
6. Crobach MJ, Dekkers OM, Wilcox MH, Kuijper EJ. 2009. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): data review and recommendations for diagnosing Clostridium difficile-infection (CDI). Clin Microbiol Infect 15:1053-1066. http://dx.doi.org/10.1111/j.1469-0691.2009.03098.x.
7. Rupnik M. 2008. Heterogeneity of large clostridial toxins: importance of Clostridium difficile toxinotypes. FEMS Microbiol Rev 32:541-555. http://dx.doi.org/10.1111/j.1574-6976.2008.00110.x.
8. Lemee L, Dhalluin A, Testelin S, Mattrat M-A, Maillard K, Lemeland J-F, Pons J-L. 2004. Multiplex PCR targeting tpi (triose phosphate isomerase), tcdA (toxin A), and tcdB (toxin B) genes for toxigenic culture of Clostridium difficile. J Clin Microbiol 42:5710-5714. http://dx.doi.org/10.1128/JCM.42.12.5710-5714.2004.
9. Persson S, Torpdahl M, Olsen KEP. 2008. New multiplex PCR method for the detection of Clostridium difficile toxin A (tcdA) and toxin B (tcdB) and the binary toxin (cdtA/cdtB) genes appliedto a Danish strain collection. Clin Microbiol Infect 14:1057-1064. http://dx.doi.org/10.1111/j.1469-0691.2008.02092.x.
10. Spigaglia P, Mastrantonio P. 2002. Molecular analysis of the patho-genicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates. J Clin Microbiol 40:3470-3475. http://dx.doi.org/10.1128/JCM.40.9.3470-3475.2002.
11. Rupnik M. 2010. Clostridium difficile toxinotyping. Methods Mol Biol 646:67-76. http://dx.doi.org/10.1007/978-1-60327-365-7-5.
12. Dingle KE, Elliott B, Robinson E, Griffiths D, Eyre DW, Stoesser N, Vaughan A, Golubchik T, Fawley WN, Wilcox MH, Peto TE, Walker AS, Riley TV, Crook DW, Didelot X. 2014. Evolutionary history of the Clostridium difficile pathogenicity locus. Genome Biol Evol 6:36-52. http://dx.doi.org/10.1093/gbe/evt204.
13. Elliott B, Squire MM, Thean S, Chang BJ, Brazier JS, Rupnik M, Riley TV. 2011. New types of toxin A-negative, toxin B-positive strains among clinical isolates of Clostridium difficile in Australia. J Med Microbiol 60: 1108-1111. http://dx.doi.org/10.1099/jmm.0.031062-0.
14. Squire MM, Carter GP, Mackin KE, Chakravorty A, Noren T, Elliott B, Lyras D, Riley TV. 2013. Novel molecular type of Clostridium difficile in neonatal pigs, Western Australia. Emerg Infect Dis 19:790-792. http://dx.doi.org/10.3201/eid1905.121062.
15. Elliott B, Reed R, Chang BJ, Riley TV. 2009. Bacteremia with a large clostridial toxin-negative, binary toxin-positive strain of Clostridium difficile. Anaerobe 15:249-251. http://dx.doi.org/10.1016/j.anaerobe.2009.08.006.
16. Braun V, Hundsberger T, Leukel P, Sauerborn M, von Eichel-Streiber C. 1996. Definition of the single integration site of the pathogenicity locus in Clostridium difficile. Gene 181:29-38. http://dx.doi.org/10.1016/S0378-1119(96)00398-8.